SEC 13F Intelligence

Managers / Q3 2024 · view latest →

Long Corridor Asset Management Ltd

CIK 0001845501 · SUITE 1901, 8QRC, 8 QUEEN'S ROAD CENTRAL, CENTRAL, HONG KONG, K3, 0000 · 852 2117 2586

Reported Value
$113M
Q3 2024
Positions
20
Filings on Record
22
2019–present window
Filed
Nov 12, 2024
original filing

Summary

Long Corridor Asset Management Ltd reported $113M in U.S.-listed holdings across 20 positions for Q3 2024.

Its largest position, META, represents 16.6% of the portfolio.

Compared with Q2 2024, the fund opened 6 new positions and exited 7.

Portfolio Metrics

Turnover
+11.1%
vs prior filed quarter
Top-10 Concentration
+91.1%
share of reported value
Largest Position
+16.6%
Meta Platforms
New / Exited
6 / 7
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’20: $114MQ4 ’20Q1 ’21: $134MQ2 ’21: $103MQ3 ’21: $85MQ3 ’21Q4 ’21: $50MQ1 ’22: $82MQ2 ’22: $119MQ2 ’22Q3 ’22: $109MQ4 ’22: $89MQ1 ’23: $83MQ1 ’23Q2 ’23: $93MQ3 ’23: $114MQ4 ’23: $120MQ4 ’23Q1 ’24: $113MQ2 ’24: $106MQ3 ’24: $113MQ3 ’24Q4 ’24: $133MQ1 ’25: $137MQ2 ’25: $277MQ2 ’25Q3 ’25: $245MQ4 ’25: $1.5BQ1 ’26: $411MQ1 ’26filingsflow.com

Portfolio Composition

By security type
Common Stock: 43.3%ADR: 34.9%US DOMESTIC: 14.0%GLOBAL: 7.7%Other: 0.1%
  • Common Stock · 43.3% · $49M
  • ADR · 34.9% · $40M
  • US DOMESTIC · 14.0% · $16M
  • GLOBAL · 7.7% · $9M
  • Other · 0.1% · $103,700

Quarter-over-Quarter Changes full breakdown →

vs Q2 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
ZGZILLOW GROUP INCNEW+56.2K56.2K+$3M$3M
XPEVXPENG INCNEW+126.8K126.8K+$2M$2M
ACTUACTUATE THERAPEUTICS INCNEW+125.0K125.0K+$931,250$931,250
CGEMCULLINAN THERAPEUTICS INCNEW+15.0K15.0K+$251,100$251,100
KURAKURA ONCOLOGY INCNEW+10.0K10.0K+$195,400$195,400
SNDXSYNDAX PHARMACEUTICALS INCNEW+10.0K10.0K+$192,500$192,500
MNSOMINISO GROUP HLDG LTDADDED+142.4K228.0K+$2M$4M
BEKEKE HLDGS INCSOLD OUT−151.3K0−$2M$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2024

20 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1METAMETA PLATFORMS INChistory →CL A16.65%$19M33.0K
2BILIBILI INCNOTE 0.500%12/014.02%$16M16.00M
3GOOGLALPHABET INChistory →CAP STK CL A13.15%$15M90.0K
4WBWEIBO CORPhistory →SPONSORED ADR10.58%$12M924.9K
5BABAALIBABA GROUP HLDG LTDhistory →SPONSORED ADS9.35%$11M100.0K
6NIO INCNOTE 0.500% 2/07.74%$9M9.00M
7AXPAMERICAN EXPRESS COhistory →COM5.97%$7M25.0K
8ONCBEIGENE LTDhistory →SPONSORED ADR5.10%$6M25.8K
9SESEA LTDhistory →SPONSORD ADS4.98%$6M60.0K
10MNSOMINISO GROUP HLDG LTDhistory →SPONSORED ADS3.52%$4M228.0K
11ZGZILLOW GROUP INChistory →CL A3.07%$3M56.2K
12NYTNEW YORK TIMES COhistory →CL A1.47%$2M30.0K
13NY4BCLEARWAY ENERGY INChistory →CL A1.38%$2M54.7K
14XPEVXPENG INChistory →ADS1.36%$2M126.8K
15ACTUACTUATE THERAPEUTICS INCCOM0.82%$931,250125.0K
16CGEMCULLINAN THERAPEUTICS INCCOM0.22%$251,10015.0K
17GLUEMONTE ROSA THERAPEUTICS INCCOM0.19%$212,00040.0K
18KURAKURA ONCOLOGY INCCOM0.17%$195,40010.0K
19SNDXSYNDAX PHARMACEUTICALS INCCOM0.17%$192,50010.0K
20OMEGA THERAPEUTICS INCCOMMON STOCK0.09%$103,70085.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$411M38May 12, 202613F-HRchanges · EDGAR ↗
Q4 2025$1.5B20Feb 12, 202613F-HRchanges · EDGAR ↗
Q3 2025$245M23Nov 13, 202513F-HRchanges · EDGAR ↗
Q2 2025$277M17Aug 12, 202513F-HRchanges · EDGAR ↗
Q1 2025$137M18May 13, 202513F-HRchanges · EDGAR ↗
Q4 2024$133M20Feb 12, 202513F-HRchanges · EDGAR ↗
Q3 2024$113M20Nov 12, 202413F-HRchanges · EDGAR ↗
Q2 2024$106M21Aug 13, 202413F-HRchanges · EDGAR ↗
Q1 2024$113M12May 13, 202413F-HRchanges · EDGAR ↗
Q4 2023$120M12Feb 9, 202413F-HRchanges · EDGAR ↗
Q3 2023$114M15Oct 30, 202313F-HRchanges · EDGAR ↗
Q2 2023$93M17Aug 11, 202313F-HRchanges · EDGAR ↗
Q1 2023$83M16May 5, 202313F-HRchanges · EDGAR ↗
Q4 2022$89M18Feb 13, 202313F-HRchanges · EDGAR ↗
Q3 2022$109M14Nov 8, 202213F-HRchanges · EDGAR ↗
Q2 2022$119M13Jul 22, 202213F-HRchanges · EDGAR ↗
Q1 2022$82M12Apr 25, 202213F-HRchanges · EDGAR ↗
Q4 2021$50M9Feb 9, 202213F-HRchanges · EDGAR ↗
Q3 2021$85M11Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$103M12Aug 10, 202113F-HRchanges · EDGAR ↗
Q1 2021$134M13May 12, 202113F-HRchanges · EDGAR ↗
Q4 2020$114M11Feb 16, 202113F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.